Advertisement

Topics

Search Results for "Alzheimers Disease Update"

16:51 EDT 17th October 2017 | BioPortfolio

Matching Channels

Vascular Dementia

Vascular Dementia accounts for 25% of all dementias (the second most commen cause after Alzheimers. It is the cumulative effects of many small strokes - patients often have evidence of vascular path...

Eye disease

Gaucher's disease

Gaucher's (go-SHAYZ) disease occurs when certain harmful fatty substances accumulate to excessive levels in your liver, spleen, lungs, bone marrow and, less commonly, brain. This accumulation of...

Mayaro disease

MarchiafavaBignami Disease

Matching News

Can we use immunotherapy to treat or delay Alzheimers Disease?

I have a personal interest in Alzheimers Disease, my mother Audrey died from it three years ago back in 2014.…

Infographic: Brain Infection and Alzheimers Disease Pathology

Emerging evidence links bacterial or viral infection with the neuropathology of Alzheimer's disease.

Do Microbes Trigger Alzheimers Disease?

The once fringe idea is gaining traction among the scientific community.

Update: Potential Breakthrough Treatment for Deadly Lung Disease Starts Phase IIb

Update (26/07/2017): Verona Pharma has dosed the first patients in the PhaseIIb with RPL554 in patients with chronic obstructive pulmonary disease (COPD). Results are expected in the second half of 2...

Update: Finnish Biotech to Raise £10M for Rare Lung Disease Drug

Update (10/10/2017): Faron Pharmaceuticals’ fundraising has been oversubscribed, which reflects the excitement around its drug candidate, Traumakine. By securing £10M, Faron matches its IPO ...

Update: British Biotech’s Gene Therapy for Rare ‘Bubble Baby’ Disease set on UK Fast-Track

UPDATE (23/08/2017): The UK has also prioritized OTL-101 for review as a ‘Promising Innovative Medicine.’ This is the first step on the path to the Early Access to Medicine Scheme to bring...

A New Edition of Human Reproduction Update Is Now Available

Human Reproduction Update (vol. 23, no. 5, 2017) is available online by subscription only. Articles include: “Novel Reproductive Technologies to Prevent Mitochondrial Disease” by Lyndsey C...

Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease

The treatment of inflammatory bowel disease (IBD)—ulcerative colitis (UC) and Crohn’s disease (CD)—has evolved beyond surgery with the introduction of biologic agents, primarily antibodies again...

Matching PubMed Articles

Cardiovascular rehabilitation and prevention guideline update.

The recent update of the ESC guidelines for cardiovascular disease prevention are in total the sixth review of these recommendations. This manuscript summarizes the newest adaptations and will provide...

Update on Graves disease: advances in treatment of mild, moderate and severe thyroid eye disease.

To report the most recent therapeutic advances of thyroid eye disease (TED) and offer general recommendations for management of TED.

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.

To update the evidence for the efficacy of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) to inform European League Against Rheumatism (EULAR) Ta...

Ocular Syphilis: An Update.

This review aims to provide an update on the clinical presentation, diagnosis, and treatment of ocular syphilis. While ocular syphilis is not a new phenomenon, recent resurgence in the incidence of ov...

Creutzfeldt-Jakob disease surveillance in Australia: update to December 2015.

Nation-wide surveillance of human transmissible spongiform encephalopathies (also known as prion diseases), the most common being Creutzfeldt-Jakob disease, is performed by the Australian National Cre...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement